LifeArc provides £5 million funding to increase understanding of the role of genetic risk factors in patient response to COVID-19
February 15, 2021: Medical research charity, LifeArc, announces today that it is providing £5 million funding to…
February 15, 2021: Medical research charity, LifeArc, announces today that it is providing £5 million funding to…
At a time when the world is looking to science for the answers, LifeArc marks the UN’s…
London, February 8, 2021: LifeArc announced today a £10 million cornerstone investment in the funding cycle of…
A new partnership between LifeArc and the US-based Crohn’s & Colitis Foundation (Foundation) aims to progress encouraging…
Ongoing collaboration extended for another 12 months and successfully progresses into late stage hit-to-lead optimisation phase Cambridge…
A new COVID-19 drug screening and resistance hub will be established in Scotland, based at the MRC-University…